Groton, MA, United States of America

Mary A Cromwell

USPTO Granted Patents = 3 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Groton, MA (US) (2015)
  • Bridgewater, NJ (US) (2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Celebrating Innovation: The Contributions of Mary A. Cromwell

Introduction: Mary A. Cromwell, a trailblazing inventor based in Groton, MA, has significantly impacted the field of biotechnology. With a strong focus on developing novel therapeutic compounds, she holds three patents that address critical medical challenges. Her work is particularly noteworthy for its contributions to the treatment of rare metabolic diseases.

Latest Patents: Among her most recent innovations are two pivotal patents: the first, titled "UDP glycosyltransferase inhibitors and methods of use," details a compound capable of treating Krabbe's Disease (KD) and Metachromatic leukodystrophy (MLD). This invention outlines not only the compound of Formula (I) but also its pharmaceutically acceptable salts and their utility in treating various conditions. The second significant patent, "Glucosylceramide synthase inhibitors," relates to compounds designed to inhibit glucosylceramide synthase (GCS). These inhibitors are essential for treating lysosomal storage diseases and can be used synergistically with enzyme replacement therapy and in cancer treatment.

Career Highlights: Mary A. Cromwell's professional journey is marked by her association with Genzyme Corporation, a leader in biotechnology focusing on rare diseases. Throughout her career, she has developed a keen expertise in biopharmaceutical innovation, particularly in the realm of metabolic disorders. Her patents reflect a deep understanding of the biochemical mechanisms underlying these diseases.

Collaborations: Collaboration is key in the field of innovation, and Mary has worked alongside talented individuals such as Bradford Hirth and Elina Makino. Together, they have advanced the study of glycosyltransferases and developed groundbreaking methods for the treatment of complex diseases.

Conclusion: Mary A. Cromwell stands out as an influential figure in biotechnology, demonstrating how dedication and creativity can lead to impactful inventions. Through her patents, she continues to pave the way for new treatments, highlighting the importance of innovation in addressing unmet medical needs. As the field evolves, her contributions will undoubtedly inspire future inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…